3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
3
Conditions
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdoid Tumor
1
Neoplasms
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Advanced Liver Cancers
1
Interventions
Carboplatin
73
pembrolizumab
70
Pemetrexed
63
Cisplatin
48
Paclitaxel
27
Nivolumab
27
durvalumab
25
osimertinib
24
Specimen Handling
24
Docetaxel
24
Magnetic Resonance Spectroscopy
20
Gemcitabine
18
atezolizumab
15
130-nm albumin-bound paclitaxel
15
amivantamab
14
Cetuximab
14
lazertinib
11
Radiotherapy
11
Radiosurgery
11
Bevacizumab
10
Ipilimumab
9
cemiplimab
8
Taxes
8
alectinib
7
Ramucirumab
7
Observation
7
Drug Therapy
7
Radiation
6
Leucovorin
6
Fluorouracil
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Tiragolumab
×
30 days
×
Clear all
NCT04513925
2026-06-03
SKYSCRAPER-03
Hoffmann-La Roche
Phase 3
Completed
829 enrolled
40 charts
NCT04619797
2026-06-03
SKYSCRAPER-06
Hoffmann-La Roche
Phase 2/3
Completed
542 enrolled
28 charts
NCT03337698
2026-05-12
Morpheus Lung
Hoffmann-La Roche
Phase 1/2
Terminated
314 enrolled
31 charts